investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Parthenon LLC Q4 2022 vs. Q1 2023: Insights on Fund Holdings Changes

Ava Hoppe | 10 May, 2023

As we move forward into a new year, it's always fascinating to reflect on the changes made by prominent companies and investors during the previous period. In this regard, we are presenting a report on Parthenon LLC Q4 2022 vs. Q1 2023 13F holdings comparison. The report provides an analysis of the holdings of Parthenon LLC, a private equity firm based in Boston, Massachusetts.

Parthenon LLC manages a diversified portfolio of companies across different sectors, including technology, healthcare, consumer retail, and industrials. The firm employs a value-oriented investment approach to achieve its long-term investment objectives.

In the Q4 2022 period, Parthenon LLC had total holdings with a value of $573,077, represented by 43 stocks. In the Q1 2023 period, Parthenon LLC increased its portfolio's size, translating to a total value of $657,221, with holdings in 47 stocks. The total value of holdings grew by 14.7% quarter-over-quarter.

Here are some of the key takeaways from the report, highlighting the significant changes made in the portfolio of Parthenon LLC:

Microsoft (MSFT)

Parthenon LLC maintained its ownership of Microsoft shares, with total holdings amounting to 279,951 shares in both quarters. In terms of value, the Q4 2022 figure was $67,237, increasing to $80,709, representing a percentage change of 20%.

Apple Inc (AAPL)

Apple Inc was a top performer for Parthenon LLC, as the firm increased its shares by 3,500, translating to a 2.7% change, from 130,131 shares in Q4 2022 to 128,491 in Q1 2023. The value of holdings in AAPL rose by 25.3%, from $16,907 to $21,188.

Meta Platforms Inc (META)

Parthenon LLC recorded an impressive 76.7% increase in its holding of Meta Platforms Inc (formerly Facebook) shares from 79,861 shares in Q4 2022 to 80,111 in Q1 2023. The value of holdings rose from $9,610 to $16,978 over the two quarters.

Johnson & Johnson (JNJ)

Parthenon LLC reduced its holdings in Johnson & Johnson by 260 shares, a 0.2% change, from 146,254 shares in Q4 2022 to 146,514 in Q1 2023. The value of holdings decreased by 12.1%, from $25,835 to $22,709, representing a below-average performance in the healthcare sector.

CVS Health Corp (CVS)

Parthenon LLC decreased its shareholding in CVS Health Corp by 3,725, translating to a 2.34% change from 159,328 shares in Q4 2022 to 163,053 in Q1 2023. The decrease led to a percentage change in the value of holdings, which dropped by 18.4%, from $14,847 to $12,116.

In conclusion, the report highlights a general trend of growth in Parthenon LLC's portfolio, with a significant increase in the total value of holdings between the quarters. The firm maintained its position in some top-performing technology companies such as Microsoft and Apple Inc, and also had an outstanding performance in companies such as Meta Platforms Inc.

On the other hand, the portfolio witnessed a decrease in holdings in companies such as Johnson & Johnson and CVS Health Corp. As always, investors are advised to carry out additional research before investing in any of the stocks highlighted in this report.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.